Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer.
Indian J Med Sci
;
1998 Jun; 52(6): 244-7
Artigo
em Inglês
| IMSEAR
| ID: sea-68661
ABSTRACT
40 cases postmenopausal women with breast cancer constituted the study group and 20 sex and age matched formed the control group. The study group of untreated patients showed nonsignificant decrease in molybdenum but significant decrease in blood xanthine oxidase and riboflavin levels. Tamoxifen treated patients showed nonsignificant increase in molybdenum, after 3 months, significant increase after 6 months and significant increase in xanthine oxidase and riboflavin levels. Thus tamoxifen when given in breast cancer helps in amelioration of the diseased condition.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Riboflavina
/
Tamoxifeno
/
Xantina Oxidase
/
Neoplasias da Mama
/
Feminino
/
Humanos
/
Pós-Menopausa
/
Antineoplásicos Hormonais
/
Pessoa de Meia-Idade
/
Molibdênio
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
Indian J Med Sci
Ano de publicação:
1998
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS